Cargando…

Comparison of prevalence and evolution of COVID-19 olfactory disorders in patients infected by D614 (wild) and B.1.1.7. Alpha variant: a brief report

OBJECTIVES: To investigate the prevalence and the evolution of olfactory disorders (OD) related to coronavirus disease 2019 (COVID-19) in patients infected during the first and the second European waves. METHODS: From March 2020 to October 2020, COVID-19 patients with OD were recruited and followed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lechien, Jerome R., Wajsblat, Shannon, Horoi, Mihaela, Boscolo-Rizzo, Paolo, Le Bon, Serge D., Vaira, Luigi A., Saussez, Sven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029791/ https://www.ncbi.nlm.nih.gov/pubmed/36943439 http://dx.doi.org/10.1007/s00405-023-07923-z

Ejemplares similares

Validity and reliability of a french version of the olfactory disorders questionnaire
por: Lechien, Jérôme R., et al.
Publicado: (2022)

Effectiveness and safety of PRP on persistent olfactory dysfunction related to COVID-19
por: Steffens, Younès, et al.
Publicado: (2022)

The study of olfactory dysfunction in SARS-CoV-2 variants
por: Vaira, Luigi A., et al.
Publicado: (2022)

Effectiveness of olfactory training in COVID-19 patients with olfactory dysfunction: a prospective study
por: Lechien, Jerome R., et al.
Publicado: (2022)

Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction
por: Lechien, Jerome R., et al.
Publicado: (2022)

Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell
por: Le Bon, Serge-Daniel, et al.
Publicado: (2021)

Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study
por: Saussez, Sven, et al.
Publicado: (2021)

The detection of smell disorder depends on the clinical tools
por: Lechien, Jerome R., et al.
Publicado: (2022)

The study of recovery rates of COVID-19 olfactory and gustatory dysfunctions requires psychophysical evaluations
por: Lechien, Jerome R., et al.
Publicado: (2021)

Analysis of the correlations between the severity of lung involvement and olfactory psychophysical scores in coronavirus disease 2019 (COVID‐19) patients
por: Amadu, Antonio Matteo, et al.
Publicado: (2021)

The Trajectories of Olfactory Dysfunction from the First to the Omicron Wave: Are We Getting over it?
por: Vaira, Luigi Angelo, et al.
Publicado: (2022)

Therapies for COVID-19-Related Persistent Olfactory Disorders: One of the Good Fruits of the Pandemic
por: Saussez, Sven, et al.
Publicado: (2023)

COVID-19 related persistent olfactory disorders represent an unprecedented challenge
por: Vaira, Luigi Angelo, et al.
Publicado: (2023)

In reply to: IL-6 serum level and olfactory dysfunction severity in COVID-19: correspondence
por: Vaira, Luigi Angelo, et al.
Publicado: (2022)

The role of nasal immunoglobulins in the recovery of olfactory function in COVID-19 patients
por: Vaira, Luigi Angelo, et al.
Publicado: (2022)

The Effects of Persistent Olfactory and Gustatory Dysfunctions on Quality of Life in Long-COVID-19 Patients
por: Vaira, Luigi Angelo, et al.
Publicado: (2022)

Injection of Platelet Rich Plasma in the Olfactory Cleft for COVID-19 Patients With Persistent Olfactory Dysfunction: Description of the Technique
por: Lechien, Jerome R., et al.
Publicado: (2022)

Specific Therapy of Olfactory Disorders in COVID-19 Patients is Essential for the Prevention of Long-term Dysfunction
por: Vaira, Luigi Angelo, et al.
Publicado: (2021)

Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients
por: Le Bon, Serge-Daniel, et al.
Publicado: (2020)

Post-viral olfactory loss and parosmia
por: Liu, Zhen Yu, et al.
Publicado: (2023)

Do olfactory and gustatory psychophysical scores have prognostic value in COVID-19 patients? A prospective study of 106 patients
por: Vaira, Luigi Angelo, et al.
Publicado: (2020)

More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival
por: Hopkins, Claire, et al.
Publicado: (2021)

Recovery from olfactory and gustatory dysfunction following COVID-19 acquired during Omicron BA.1 wave in Italy()
por: Boscolo-Rizzo, Paolo, et al.
Publicado: (2023)

Parosmia assessment with structured questions and its functional impact in patients with long‐term COVID‐19–related olfactory dysfunction
por: Boscolo‐Rizzo, Paolo, et al.
Publicado: (2022)

Objective Olfactory Findings in Hospitalized Severe COVID-19 Patients
por: Lechien, Jerome R., et al.
Publicado: (2020)

Olfactory epithelium histopathological findings in long-term coronavirus disease 2019 related anosmia
por: Vaira, L A, et al.
Publicado: (2020)

Post-COVID-19 Dysphonia may have Several Origins
por: Lechien, Jerome R., et al.
Publicado: (2021)

A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model
por: Frise, Rebecca, et al.
Publicado: (2022)

Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study
por: Vaira, Luigi Angelo, et al.
Publicado: (2021)

Remote psychophysical evaluation of olfactory and gustatory functions in early-stage coronavirus disease 2019 patients: the Bologna experience of 300 cases
por: Petrocelli, M, et al.
Publicado: (2020)

Rare anatomic variation: Nasopharyngeal middle turbinate
por: Lechien, Jérôme R., et al.
Publicado: (2019)

Chemosensory dysfunction in COVID-19: Is there really a correlation with viral load?
por: Vaira, Luigi Angelo, et al.
Publicado: (2021)

The interest of fluticasone nasal spray in COVID-19 related anosmia is still not demonstrated
por: Lechien, Jerome R., et al.
Publicado: (2021)

Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays
por: Virtanen, Jenni, et al.
Publicado: (2021)

Hearing aid and Koebner phenomenon
por: Lechien, Jérôme R., et al.
Publicado: (2020)

Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study
por: Vaira, L A, et al.
Publicado: (2020)

Prevalence of acute olfactory dysfunction differs between variants of SARS-CoV-2—results from chemosensitive testing in wild type, VOC alpha (B.1.1.7) and VOC delta (B.1617.2)
por: Hintschich, Constantin A., et al.
Publicado: (2022)

Olfactory and gustatory dysfunctions are difficult to evaluate in hospitalized COVID-19 patients
por: Vaira, Luigi A., et al.
Publicado: (2021)

Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients
por: Vaira, Luigi Angelo, et al.
Publicado: (2021)

Unilateral chronic maxillary rhinosinusitis after bone maxillary graft for dental implant placement: A case report
por: Lechien, Jerome R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2onggj2ho8afm5i386d9mlrs35